510.36 USD
↘ 3.76 (0.73%)AT CLOSE (11:59 AM EDT)
Madrigal Pharmaceuticals, Inc. Common Stock
MDGLNASDAQ • USD
511.50
↗ 1.14 (0.22%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
511.50
↗ 1.14 (0.22%)
Market: CLOSED
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently trading at $510.38. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 6, 2026.
Open?$513.28
High?$524.45
Low?$509.00
Prev. Close?$514.12
Volume?296.8K
Avg. Volume?444.3K
VWAP?$514.17
Rel. Volume?0.67x
Bid / Ask
Bid?$505.00 × 40
Ask?$518.00 × 40
Spread?$13.00
Midpoint?$511.50
Valuation & Ratios
Market Cap?11.9B
Shares Out?23.1M
Float?16.5M
Float %?71.7%
P/E Ratio?N/A
P/B Ratio?22.68
EPS?-$14.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
11.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2007-02-06
Address
1001 CONSHOHOCKEN STATE ROAD
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?62
Short Sent.?44
Piotroski F-Score?1/9Weak
Altman Z-Score?8.33Safe
Confidence?58%Low
Short InterestHigh
Short % of Float?12.48%High
Short Interest?2.1M
Days to Cover?6.9
Free Float16.5M
Avg Daily Volume297.3K
Settlement Date2026-07-15
Financial Health
Current Ratio?3.20Strong
Quick Ratio?2.94Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.65Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?22.68HIGH▾
Peers100
S&P5
P/S?9.25HIGH▾
Peers100
S&P9
P/FCF?N/A▾
EV/EBITDA?-37.1CHEAP▾
S&P97
EV/Sales?9.29HIGH▾
Peers100
S&P13
Returns & Efficiency
ROE?-62.1%WEAK▾
S&P3
ROA?-26.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-206285000
Enterprise Value?$11.9B
Fundamentals ratios updated end of day